Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd

This study tests a new drug called RK-4 for people who have had a severe stroke and cannot receive standard treatment to reopen blocked blood vessels. The drug is injected into the skull bone marrow daily for three days. Researchers want to see if it helps patients recover better…